 Connection
Ernesto Sparrelid to Capecitabine
This is a "connection" page, showing publications Ernesto Sparrelid has written about Capecitabine.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.055 |
|
|
|
-
Labori KJ, Bratlie SO, Andersson B, Angelsen JH, Bi?rserud C, Bj?rnsson B, Bringeland EA, Elander N, Garresori H, Gr?nbech JE, Haux J, Hemmingsson O, Liljefors MG, Myklebust T?, Nymo LS, Peltola K, Pfeiffer P, Sallinen V, Sandstr?m P, Sparrelid E, Stenvold H, S?reide K, Tingstedt B, Verbeke C, ?hlund D, Klint L, Dueland S, Lassen K. Neoadjuvant FOLFIRINOX versus upfront surgery for resectable pancreatic head cancer (NORPACT-1): a multicentre, randomised, phase 2 trial. Lancet Gastroenterol Hepatol. 2024 Mar; 9(3):205-217.
Score: 0.055
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|